Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy-Reference-Cited by-同舟云学术

Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy

Published:2020-07 Issue: Volume:53 Page:48-56
ISSN:1567-7249
Container-title:Mitochondrion
language:en
Short-container-title:Mitochondrion

Author:

Chung Hyemoon,Kim Yoonjung,Cho Sun-Mi,Lee Ho-Joon,Park Chul-Hwan,Kim Jong-Youn,Lee Sang-Hak,Min Pil-Ki,Yoon Young Won,Lee Byoung Kwon,Kim Woo-Shik,Hong Bum-Kee,Kim Tae Hoon,Rim Se-Joong,Kwon Hyuck Moon,Choi Eui-Young,Lee Kyung-A

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Molecular Medicine

Reference55 articles.

1. Mutations in the genes for sarcomeric proteins in Japanese patients with onset sporadic hypertrophic cardiomyopathy after age 40 years;Anan;Am. J. Cardiol.,2007

2. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA;Andrews;Nat. Genet.,1999

3. Analysis of the Z-disc genes PDLIM3 and MYPN in patients with hypertrophic cardiomyopathy;Bagnall;Int. J. Cardiol.,2010

4. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy;Bahrudin;J. Mol. Biol.,2008

5. Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management;Bates;Eur. Heart J.,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial dysfunction in the pathogenesis of hypertrophic cardiomyopathy;Morphology;2024-07-30

2. Retrofitting the Heart: Explaining the Enigmatic Septal Thickening in Hypertrophic Cardiomyopathy;Circulation: Heart Failure;2024-05

3. Gene-Specific Discriminative Echocardiogram Findings in Hypertrophic Cardiomyopathy Determined Using Artificial Intelligence: A Pilot Study;Cardiogenetics;2023-12-25

4. p21-Activated Kinases Present a New Drug Target for Hypertrophic Cardiomyopathy;International Journal of Drug Discovery and Pharmacology;2023-09-28

5. Accurate Classification of Non-ischemic Cardiomyopathy;Current Cardiology Reports;2023-09-15